ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.510
+0.050 (3.42%)
At close: Dec 20, 2024, 4:00 PM
1.624
+0.114 (7.54%)
After-hours: Dec 20, 2024, 7:01 PM EST
ProKidney Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ProKidney stock have an average target of 4.50, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 198.01% from the current stock price of 1.51.
Analyst Consensus: Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
The average analyst rating for ProKidney stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +297.35% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +98.68% | Sep 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +297.35% | Jun 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +164.90% | May 29, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.60
from -0.57
EPS Next Year
-0.45
from -0.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.57 | 0.34 | -0.55 | |||
| Avg | -0.60 | -0.45 | -0.78 | |||
| Low | -0.62 | -0.69 | -1.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.